227 related articles for article (PubMed ID: 22452602)
1. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria.
Khan S; Lynch N
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):235-43. PubMed ID: 22452602
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
Sanada S; Tanaka T; Kameyoshi Y; Hide M
Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic options in idiopathic chronic urticaria].
Mora PM; González Pérez Mdel C; Jiménez Villarruel M; Rodriguez Castro E; Fogelbach GG
Rev Alerg Mex; 2005; 52(2):77-82. PubMed ID: 16158780
[TBL] [Abstract][Full Text] [Related]
4. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.
Erbagci Z
J Allergy Clin Immunol; 2002 Sep; 110(3):484-8. PubMed ID: 12209099
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Wan KS
J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
[TBL] [Abstract][Full Text] [Related]
7. Montelukast treatment of urticaria.
McBayne TO; Siddall OM
Ann Pharmacother; 2006 May; 40(5):939-42. PubMed ID: 16670370
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.
Pacor ML; Di Lorenzo G; Corrocher R
Clin Exp Allergy; 2001 Oct; 31(10):1607-14. PubMed ID: 11678862
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene modifiers in chronic urticaria.
Bensch G; Borish L
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):348. PubMed ID: 10541429
[No Abstract] [Full Text] [Related]
11. Clinical Characteristics, Investigations and Treatment in Children with Chronic Urticaria: An Observational Study.
Buono EV; Giannì G; Scavone S; Caffarelli C
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792886
[No Abstract] [Full Text] [Related]
12. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
Nettis E; Dambra P; D'Oronzio L; Loria MP; Ferrannini A; Tursi A
Arch Dermatol; 2001 Jan; 137(1):99-100. PubMed ID: 11176678
[No Abstract] [Full Text] [Related]
13. Pharmacotherapy of chronic spontaneous urticaria.
Makris M; Maurer M; Zuberbier T
Expert Opin Pharmacother; 2013 Dec; 14(18):2511-9. PubMed ID: 24195758
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria.
Nettis E; Pannofino A; Cavallo E; Ferrannini A; Tursi A
J Allergy Clin Immunol; 2003 Jul; 112(1):212-3. PubMed ID: 12847504
[No Abstract] [Full Text] [Related]
16. Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.
Tedeschi A
Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):187-9. PubMed ID: 20128233
[TBL] [Abstract][Full Text] [Related]
17. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria.
Wan KS; Chang YS
J Dermatolog Treat; 2014 Dec; 25(6):459-61. PubMed ID: 24192062
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
20. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
